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Abstract
Background: Past studies suggest that maternal vitamin D intake during pregnancy may protect against child
wheeze but studies on asthma are limited. Our objective was to examine the relation between intake of vitamin D
in mid-pregnancy and child asthma and allergic rhinitis at 18 months and 7 years.
Methods: We examined data from 44,825 women enrolled during pregnancy in the longitudinal Danish National
Birth Cohort (1996–2002). We estimated vitamin D intake from diet and supplements based on information from a
validated food frequency questionnaire completed in gestational week 25. At 18 months, we evaluated child
asthma using data from phone interviews. We assessed asthma and allergic rhinitis by self-report at age 7 and
asthma by using records from national registries. Current asthma at age 7 was defined as lifetime asthma diagnosis
and wheeze in the past 12 months. We calculated multivariable risk ratios with 95% CIs comparing highest vs. low-
est quintile of vitamin D intake in relation to child allergic disease outcomes.
Results: The median (5%-95%ile) intake of total vitamin D was 11.7(3.0-19.4) μg/day (68% from supplements). In
multivariable analysis, mothers in the highest (vs. lowest) quintile of total vitamin D intake were less likely to have
children classified with current asthma at 7 years (Q5 vs. Q1: 0.74, 95% CI: 0.56, 0.96, P= 0.02) and they were less
likely to have children admitted to the hospital due to asthma (Q5 vs. Q1: 0.80, 95% CI: 0.64, 1.00, P= 0.05). We
found no associations with child asthma at 18 months or with allergic rhinitis at 7 years.
Conclusions: Our findings suggest a weak inverse relationship between high total vitamin D and asthma outcomes
in later, but not early, childhood. The data did not suggest a clear threshold of vitamin D intake above which risk of
asthma was reduced.
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Background
The past decades have seen a rise in allergic diseases and
it has been hypothesized that the increase in prevalence
may have its roots in utero [1-3]. Recently, low maternal
levels of vitamin D have moved to the forefront as a po-
tential causal agent [4]. Vitamin D is a prehormone that
can be synthesized in the skin from 7-dehydrocholesterol
when exposed to UV light. Through a series of hydroxyl-
ation steps vitamin D3 is converted to 25-hydroxyvitamin
D (25(OH)D), the primary metabolite, and then 1,25-
dihydroxyvitamin D (1,25(OH)2D), the active compound.
Vitamin D can also be attained through diet from foods
such as oily fish, eggs, fortified foods, and through the use
of supplements [5]. In Denmark, no foods have, however,
been enriched with vitamin D since 1985 [6]. The avail-
ability of few food sources, dietary changes away from
fatty fish consumption, and the use of sunscreen, covering
clothes and host factors (age, skin color, and body weight)
have made vitamin D deficiency a ubiquitous problem
[7-9]. In Denmark vitamin D deficiency (<20 nmol/L) was
observed in 9% of ethnic Danish non-pregnant women
[10]; 10% of women in a random sample from the cohort
* Correspondence: kmv@ssi.dk
1Centre for Fetal Programming, Department of Epidemiology Research,
Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark
Full list of author information is available at the end of the article
© 2013 Maslova et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Maslova et al. BMC Pregnancy and Childbirth 2013, 13:199
http://www.biomedcentral.com/1471-2393/13/199for the present study had 25(OH)D levels<25 nmol/L
[11]. While the importance of vitamin D for skeletal health
has long been acknowledged, more recent discovery of
receptors for vitamin D in multiple organ systems in the
body, including immune cells, suggests that the health
benefits of vitamin D may extend beyond its classic effects
[12]. Vitamin D has also been shown to influence immun-
ity by inducing cathelicidin, an antimicrobial peptide; acti-
vating T helper (Th) 1 and 2 cells through T regulatory
(Treg) cells; and has been found in activated mononuclear
leukocytes and lymphocytes [13-17].
In pregnancy, maternal 25(OH)D is the primary fetal
vitamin D source, with some potential contribution from
placental 1,25(OH)2D [18]. Epidemiological studies exam-
ining the intake of vitamin D during pregnancy have
found inverse associations primarily with wheeze and
eczema [19-21]; a recent study from the UK found no
association with dietary vitamin D and wheeze, asthma,
or sensitization [22]. Using either maternal or cord blood
25(OH)D as biomarker for fetal vitamin D exposure, stud-
ies have found mixed results of inverse [23-25], direct
[26], and null [22,27] associations with respiratory and al-
lergic disease outcomes. With few studies distinguishing
between dietary and supplement sources of vitamin D
and with only two studies including asthma [22,28] and
allergic rhinitis [28] in children above 5 years of age, we
decided to examine these relations in a large, prospective
study. These results would be important not only for
informing on recommendations for vitamin D intake
during pregnancy in relation to asthma prevention, but
also for determining the relevance of intake sources.
The objective of this study was to examine the associ-
ation between vitamin D intake from diet and supplements
during pregnancy and child allergic disease outcomes in
early and later childhood using a large, longitudinal
Danish pre-birth cohort.
Methods
Study population
The Danish National Birth Cohort (DNBC) is a large,
prospective cohort study that enrolled women from
1996–2002 during their first antenatal visit (gestational
week 6–10). Women were eligible if they could speak
Danish and planned to carry to term. A total of 35% of
all pregnancies in Denmark were enrolled (n > 100,000).
Women partook in two interviews during pregnancy
(gestational week 12 and 30) and two after birth (at 6
and 18 months). At the 25
th week of gestation they also
filled out a validated, semi-quantitative food frequency
questionnaire (FFQ) [29]. Mothers and children have
been followed up through national registries and a
questionnaire that was sent to the mothers when the
child turned 7 years. Of the 101,045 enrolled pregnan-
cies we included only singletons and first enrolled
pregnancies to avoid dependencies among correlated
measures (n=87,056). Among the 61,546 women who
had data on vitamin D intake from the FFQ, 44,825 had
information on total (diet+supplement) vitamin D intake,
limited by information on supplement use (n=45,004).
Women leaving the question on supplements blank
accounted for the missing supplement data. Sample size
further varied depending on missing outcome data.
Mothers provided written informed consent on be-
half of their children. The Regional Scientific Ethics
Committee for the municipalities of Copenhagen and
Frederiksberg approved all study protocols, and all
procedures were in accordance with the Declaration of
Helsinki.
Exposure assessment
Vitamin D intake was assessed using the mid-pregnancy-
FFQ. Maternal intakes were estimated as described
previously [30]. Briefly, specific questions were asked
about intakes from approximately 360 different foods,
and women were asked to report the frequency with
which each had been consumed during the previous
four weeks. We computed vitamin D intake by multi-
plying daily frequencies with standardized portions
and calculated into micrograms per day using Danish
food tables. All intakes were energy-adjusted using the
residual method [31]. Women who reported intake
resulting in unrealistic energy intake estimates (arbitrarily
set to <2500 kJ/day or> 25,000 kJ/day) were excluded
(356/70,188(0.5%)). Intake from supplements were calcu-
lated from the information women provided on name of
the product, the producer, nutrient content per daily dose,
and number of daily doses. We compiled a data base of
supplements using information from the Danish Veterinary
and Food Administration. This information was combined
with the frequency of intake reported by the women and
daily intake based on daily recommended intake stated on
the supplement. Majority of vitamin D supplements were
in the form of D3, though a small proportion also con-
tained D2. The data base is yet to be validated, but a similar
data base has been validated in a Norwegian pre-birth co-
hort and showed good correlation with maternal 25(OH)D
concentrations [32]. Furthermore, in our cohort we found
that dietary and supplement vitamin D predicted maternal
plasma 25(OH)D levels [11]. In our data the Spearman
correlations for vitamin D from diet and supplements with
plasma 25(OH)D were 0.07 (P=0.05) and 0.26 (P<0.001),
respectively.
Outcome assessment
We assessed outcomes at the 18 months and 7 year
follow-up. Asthma at 18 months was defined as self-
reported doctor asthma diagnosis. At the 7 year
follow-up asthma and allergic rhinitis was assessed
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and Allergies in Childhood (ISAAC) questionnaire
which was mailed to the mothers [33]. Current asthma
at age 7 was defined using a combination of two ques-
tions including one on lifetime doctor diagnosis of asthma
and one on wheezing symptoms in the past 12 months.
Only children with positive answers to both of these ques-
tions were defined as having asthma at age 7. Children
with positive answers to only one or to none of the ques-
tions were classified as not having asthma at age 7. Cases
of ever allergic rhinitis were defined based on reported
lifetime doctor diagnosis of hay fever.
We also used the mandatory Danish National Patient
Registry (DNPR) that collects data on hospital admis-
sions to define ever admitted asthma. The registry has
demonstrated good validity against asthma diagnosis
from hospital records [34]. We extracted data from the
DNPR in August 2010 and linked it to our data using
the unique identification number provided to all Danish
citizens. Cases of ever admitted asthma were identified
using the International Classification of Disease 10
(ICD-10) diagnosis codes for asthma (J45, J45.0, J45.1,
J45.8, J45.9, J46, and J46.9). We included all first cases of
admitted asthma over the entire study period (birth to
7 years of age).
The Register of Medicinal Product Statistics (RMPS)
contains detailed individual-level dispensary information
[35]. We used a previous validation study [36] to identify
Anatomical Therapeutic Chemical codes for the classifi-
cation of ever prescribed asthma cases. We defined a
case as>=2 prescriptions for beta2agonists or steroids
or>=1 prescription for any other obstructive airway dis-
ease drug. We included all first cases of prescribed asthma
over the entire study period (birth to 7 years of age).
Covariates
We collected and evaluated information on maternal
sociodemographic and lifestyle covariates during preg-
nancy from the interviews including socioeconomic sta-
tus by parental education level and occupation (SES:
high level proficiency, medium level proficiency, skilled,
unskilled, student, unemployed), maternal age at birth of
child (<20, 20–<25 , 25 –<30 , 30 –<35 , 35 –<40 , ≥40),
parity (nulli- and multiparous), maternal prepreg-
nancy BMI (in kg/m
2) (<=18.5, 18.6-24.9, 25.0-29.9,
30–34.9, >=35.0), maternal smoking (nonsmoker, occa-
sional smoker, current smoker), maternal exposure to
secondary smoke (yes/no), partner smoking (yes/no), ma-
ternal exercise (min/week), maternal outdoor activity
(min/week), month and season of last menstrual period
(LMP), maternal solarium used (weeks), gestational weight
gain (g/week in quartiles), breastfeeding duration (none,
0–1, 2–3, 4–6, 7–9, >=10 months), birth weight (in
grams), gestational age (days since the LMP in quintiles),
child sex, parental history of asthma and allergies. Dietary
covariates which have previously shown associations with
exposure or outcome were included into the multivariable
model: energy, fruit and vegetables, alcohol consumption,
and intake of n-3 fatty acids, vitamins A, C, E, folate, and
calcium, selenium, and zinc from diet and supplements
(reviewed in [37]). All covariates were self-reported except
for maternal age, month of LMP, birth weight, and gesta-
tional age, which were extracted from the national regis-
tries. The percentage of missing values was low (0-1%) for
majority of variables, apart from breastfeeding (27%) and
gestational weight gain (32%). These covariates were
poorly correlated with the exposure (Spearman rho<
=0.01) and were deemed to be weak confounders. We
therefore used the missing indicator method to account
for the missing data. A complete-case analysis did not
substantially alter the effect estimates though confi-
dence intervals were slightly wider.
Statistical analyses
We compared the distributions of vitamin D intake across
categories of age-standardized covariates. Distributions
were age-standardized due to significant differences in
vitamin D intake across age categories with older women
consuming more vitamin D compared to younger women.
Intake of vitamin D was quintilized and indicator variables
modelled comparing each quintile to the lowest, reference,
quintile. We also examined potential continuous relations
and dichotomized the exposure according to US (15 μg/d)
[38] and Nordic (10 μg/d) [39] dietary recommendations.
We further examined the possible non-linear relationship
between both the exposures and covariates and odds ratio
of child asthma non-parametrically with restricted cubic
splines [40]. Tests for non-linearity used the likelihood
ratio test, comparing the model with only the linear term
to the model with the linear and the cubic spline terms.
We found a non-linear relationship between season of
LMP and birth weight with child asthma only. To account
for the non-linearity we entered a cubic term into the final
model.
In the multivariable models we introduced covariates
that were associated with the outcome at P<0.10 in
univariate analyses. Covariates that were associated with
the outcome at P<0.05 in a multivariable model (exclud-
ing exposure), or for which there were biological priors
(parental history of asthma/allergy and child sex) were in-
cluded in the final models. Covariates initially suspected
to be on the causal pathways, such as gestational weight
gain, birth weight, and gestational age, were initially ex-
cluded from the model to avoid over-adjustment. Further
adjustment for these covariates in the final model did
not alter the results. Log-binomial models were used to
estimate relative risks (RR) and 95% CI [41,42]. In a few
instances, the models did not converge and log-Poisson
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estimates of the RR and its confidence intervals, were
used [43]. Median values for each quintile of exposure
were entered separately into the models as a continuous
variable to evaluate P-value for trend [44]. Interactions
by parental asthma and allergy history, maternal vitamin
A intake, and maternal prepregnancy BMI were exam-
ined using tertiles of vitamin D intake and evaluated
using a robust score test. Variables were chosen on the
basis of biological and physiological relevance to either
the exposure (vitamin A, maternal prepregnancy BMI)
or outcome (parental history of asthma and allergy).
Statistically significant interactions were stratified upon.
All tests were two-sided and we used a threshold of
p <0.05 to denote statistical significance. The analyses
were performed using the Statistical Analyses System
software (release 9.3; SAS Institute, Cary, NC).
Results
Study population
A total of 44,825 mothers had information on total vita-
min D intake. The majority of mothers were 25–35 years
old (73%), of medium to high level proficiency (56%), and
nulliparous (56%). Over 68% had a BMI in the normal
range (18.5-24.9 kg/m
2) and a mean gestational weight
gain of 471±212 g/week. A total of 12% reported daily
smoking during pregnancy and the far majority of women
did not exercise while pregnant (61%) or spend time doing
outdoor physical activities (83%). Most mothers did not
use tanning beds during pregnancy (74%). The LMP was
evenly distributed among seasons with slightly more
mothers reporting a LMP in the fall (26%) and winter
(26%). Mean birth weight was 3,578±571 g and mean
gestational age 280±14 days with 51% male births.
The median intake (5%-95%ile) of total vitamin D in
the study population was 11.7(3.0-19.4) μg/day (3.0(1.5-
7.4) μg/day from diet; 8.9(0.0-15.0) μg/day from supple-
ments). While the range went all the way to 81.1 μg/
day, this was mostly due to outliers. Nine percent (4,260/
45,004) reported no use of supplements; an additional 340
women had intakes<=1 μg/day.
Comparing participants (n=33,425) to non-participants
(n=11,400) for the analyses of 18 month outcomes, par-
ticipants were less likely to be nulliparous (55% vs. 60%)
and they reported lower frequency of last menstrual
period during the winter (25% vs. 30%). At 7 years, partici-
pants (n=28,687 vs. 16,138 non-participants) were more
likely to be of medium to higher socioeconomic status
(58% vs. 53%), have a normal range prepregnancy BMI
(70% vs. 65%), not to smoke during pregnancy (77% vs.
73%), and not exercise during pregnancy (60% vs. 64%).
There were few differences in maternal age, birth
weight, gestational age, and intake of micronutrients
during pregnancy.
Determinants of vitamin D intake
Table 1 shows the age-standardized distributions of covari-
ates across quintiles of total vitamin D intake. Compared
to women in the lower quintiles, women reporting higher
consumption of total vitamin D were more likely to be
nulliparous with a high level of proficiency and a normal
range BMI. They tended to be non-smokers, be less ex-
posed to second-hand smoke, and more likely to exercise.
More women in the highest quintile used tanning beds
during pregnancy. High vitamin D consumers had an
overall healthier diet with higher fruit and vegetable in-
take, and higher consumption of folate, n-3 fatty acids, cal-
cium, vitamins A, C, and E, selenium and zinc.
Similar relationships were found for dietary and supple-
mental vitamin D. Women who consumed more vitamin
D from diet furthermore breastfed>=7 months and had
their LMP in the winter months. Vitamin D supplement
users showed no difference in socioeconomic position or
smoking status (data not shown).
Multivariable analyses
Ever doctor diagnosed asthma at 18 months
The prevalence of child asthma at 18 months was 17%
(N =5,635/33,425). We found no associations for either
total vitamin D, vitamin D from supplements or diet
(Tables 2 and 3; Additional file 1: Table S1). We found
suggestion of an inverse relationship between dietary
vitamin D and asthma diagnosis in the first 18 months
of life, but this association disappeared after further adjust-
ment for dietary covariates (Additional file 1: Table S1).
Current and ever asthma at 7 years
At age 7 years 6% (N=1,654/28,767) of children were
classified with ever admitted asthma and 31% (N=8,906/
28,758) with ever prescribed asthma. The prevalence of
current asthma at age 7 was 4% (N=1,122/28,687). After
adjustment for sociodemographic and dietary covariates,
we found an inverse, though modest, association for total
vitamin D intake with both current asthma at age 7 (con-
tinuous: 0.99, 95% CI: 0.97, 1.00, P=0.09; Q5 vs. Q1: 0.74,
95% CI: 0.56, 0.96) and ever admitted asthma (continuous:
0.99, 95% CI: 0.97, 1.00, P=0.08; Q5 vs. Q1: 0.80, 95% CI:
0.64, 1.00) (Table 2). We found null relationships for
vitamin D from supplements and diet; though a ten-
dency towards an inverse association was present for
continuous vitamin D from supplements with both
current asthma and ever admitted asthma (Table 3). We
found no association for any of the vitamin D exposures
with ever prescribed asthma (Tables 2 and 3; Additional
file 1: Table S1).
Since 1995 the DNPR has contained information on
whether patients are diagnosed as inpatients, outpatients,
or in an emergency department (ED). There were too few
ED cases to allow models to converge, but for inpatient
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Quintile of total maternal vitamin D in pregnancy
1
12 3 4 5
(n=8965) (n=8965) (n=8965) (n=8965) (n=8965)
Total Vitamin D (μg/day)
Median 5.5 8.2 11.7 13.0 16.5
5%-95%ile 1.8-7.1 7.3-9.4 9.9-12.3 12.4-14.0 14.2-27.4
Vitamin D from supplement (μg/day)
Median 0 5.0 7.1 10.0 15.0
Vitamin D from diet (μg/day)
Median 1.8 2.4 3.0 4.0 5.9
Maternal age in years (mean±SD)
2
<=20 (19.2±1.0) 2 1 2 2 1
20-25 (23.7±1.3) 19 16 20 20 16
25-30 (28.0±1.4) 44 45 46 45 46
30-35 (32.7±1.4) 28 30 25 26 29
>35 (37.6±1.7) 8 7 6 7 8
Parity
Nulliparous 49 52 59 58 63
Socioeconomic position
High level proficiencies 22 24 24 22 27
Medium level proficiencies 32 32 32 32 32
Skilled 28 27 27 28 25
Unskilled 13 12 12 13 11
Students 3 4 3 3 4
Unemployed 2 2 1 2 1
Pre-pregnancy BMI in kg/m
2 (mean±SD)
<=18.5 (17.8±0.7) 4 4 4 5 4
18.6-24.9 (21.7±1.7) 67 69 68 67 70
25-29.9 (27.0±1.4) 20 20 20 20 18
>=30 (33.7±4.1) 8 8 8 8 7
Breastfeeding duration
No breastfeeding 2 2 3 2 2
0-1 months 10 9 10 9 9
2-3 months 10 10 11 11 11
4-6 months 19 18 19 19 18
>=7 months 59 61 57 58 60
Smoking in pregnancy
Nonsmoker 75 76 76 74 77
Occasional smoker 12 12 13 14 14
Current smoker 12 11 12 12 10
Second-hand smoking
Yes 46 46 45 47 44
Partner smoking
Yes 29 28 29 29 28
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(Continued)
Physical activity in min/week (mean±SD)
0 (0±0) 64 61 61 61 57
1-44 (29±7) 5 5 5 5 6
45-74 (57±7) 9 10 9 9 10
75-149 (105±19) 11 12 12 12 13
>=150(265±162) 11 12 12 12 14
Outdoor activity in min/week (mean±SD)
0 (0±0) 83 83 83 83 82
1-59 (35±11) 3 2 2 2 2
60-119 (79±17) 5 6 5 5 6
>=120 (237±168) 9 9 10 9 10
Maternal asthma
Yes 9 9 10 9 10
Maternal allergy
Yes 32 32 32 32 33
Paternal asthma
Yes 8 9 8 8 8
Paternal allergy
Yes 24 25 25 24 26
Season of LMP
Winter 27 26 26 25 27
Spring 25 23 25 26 24
Summer 21 24 23 24 23
Fall 27 27 26 25 26
Total solarium use in pregnancy in weeks (mean±SD)
0 (0±0) 76 75 74 74 72
1-3 (1.5±0.7) 14 15 16 15 16
4-20 (9.7±4.8) 8 8 8 9 9
21-40 (30.3±4.0) 2 2 2 2 3
Child sex (male) 50 51 51 51 52
Gestational weight gain (g/week) 469(214) 468(211) 473(215) 474(213) 473(208)
Gestational age (days) 280(13) 280(13) 280(12) 280(13) 280(13)
Birth weight (g) 3,584(571) 3,598(571) 3,578(564) 3,572(567) 3,557(578)
Maternal food and nutrient intake
Fruit intake (g/day)
3 325(275) 319(255) 346(294) 332(265) 344(260)
Vegetables intake (g/day)
3 125(98) 129(95) 130(98) 130(93) 148(106)
Energy (kJ/day) 10,073(2,683) 10,257(2,613) 9,919(2,637) 10,226(2,703) 9,727(2,663)
Alcohol (g/day) 1.6(2.3) 1.6(2.4) 1.5(2.1) 1.5(2.0) 1.6(2.3)
Total folate (μg/day) 466(188) 567(215) 680(162) 726(148) 758(224)
Total calcium (mg/day) 1,456(490) 1,541(486) 1,526(516) 1,582(519) 1,753(618)
Total EPA+DPA+DHA (mg/day) 48.3(318.3) 50.4(311.0) 65.0(359.9) 48.3(315.8) 75.4(396.8)
Total vitamin A (μg/day) 1,227(557) 1,659(469) 1,399(506) 1,351(439) 1,545(669)
Total vitamin E (mg/day) 16.4(34.8) 22.0(26.3) 19.6(29.1) 17.8(22.9) 23.8(40.0)
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D consumption and admitted asthma (Q5 (171/5,304) vs.
Q1 (190/5,387): 0.73, 95% CI: 0.54, 1.00, P=0.04).
Ever allergic rhinitis at 7 years
The prevalence of child ever allergic rhinitis was 5%
(N =1,420/28,545). No associations were found for ei-
ther total vitamin D intake, or vitamin D from supple-
ments or diet (Table 4).
Sensitivity analyses
We further examined any wheeze and recurrent wheeze
(>3 episodes vs. <=3 episodes or no wheeze) at 18 months
and found no associations for any exposure after adjusting
for covariates (data not shown).
Categorizing the total vitamin D intake in 5 μg/day
increments (from zero to>=25 μg/day) or 2.5 μg/day
(from zero to>=15 μg/day) did not show any association,
except for asthma at 18 months which showed an inverse
association for total vitamin D>=20 μg/day vs. none
(0.76, 95% CI: 0.59, 0.96, P=0.02). Examining vitamin D
intake by dichotomizing it according to US (15 μg/day)
and Nordic (10 μg/day) recommendations, we found no
associations with any of the outcomes (data not shown).
Respiratory symptoms in early childhood may involve
pathologies and etiologies that are different from clinical
asthma [45]. We therefore excluded the first 3 years of life
from the registry-based outcomes. The number of admitted
cases more than halved, and the number of prescription-
related asthma cases was reduced by close to 80%. This
reduced the significant associations to null, altering the
effect estimates and widening the confidence intervals.
The association between total vitamin D and ever pre-
scribed asthma was borderline significant (Q5 vs. Q1: 0.82,
95% CI: 0.67, 1.00, P = 0.05).
We found no interactions by parental history of asthma
and allergy, or by maternal vitamin A intake. Stratifying
on maternal prepregnancy BMI, we found that the associ-
ations for maternal total vitamin D intake with child
current asthma at age 7 (Q5 vs. Q1: 0.67, 95% CI: 0.49,
0.92, P=0.01) and ever admitted asthma (Q5 vs. Q1: 0.74,
95% CI: 0.56, 0.96, P=0.03) were stronger for women with
a BMI between 18.6 and 24.9 kg/m
2 compared to women
with a BMI>=25 kg/m
2 where the results were null.
Women in the<=18.5 kg/m
2 group were too few to assess
any meaningful effect modification.
Discussion
In this large, longitudinal study of over 40,000 mother-
child dyads with detailed dietary and supplement data in
pregnancy, we found weak inverse associations for ma-
ternal total vitamin D intake with ever admitted and
current child asthma at age 7 only. This association
appeared to be accounted for by supplemental vitamin D
as two-thirds of maternal intake came from supplements
and trends towards similar associations were found for
supplemental vitamin D. We found no associations for
asthma at 18 months, ever prescribed asthma, or allergic
rhinitis.
The total vitamin D intake in our study population had
a mean of 11.2 μg/day with a 5
th-95
th% of 3.0-19.4 μg/day
(or 440 IU/day; 5
th-95
th%: 120-776 IU/day), with 304 IU/
day coming from supplements. This is higher than what
has been found in Finnish (204 IU/day, no range given)
[28], UK (137 IU/day, 5
th-95
th%: 67-445 IU/day) [20], and
Japanese (248 IU/day, no range given) [21] populations,
which all had low supplement use (5-30% vs. 68% in the
DNBC) [46]; but lower than in a US cohort (548 IU/day;
319 IU/day from supplements; range 60–1,145 IU/day)
[19]. Differences in intake range from supplements vs.
diet between our and prior studies could explain why
our significant results were limited to vitamin D from
supplements. Dietary recommendations for vitamin D
during pregnancy are subject to debate and uncertainty
exists regarding optimal levels needed to attain poten-
tial benefits of vitamin D [47]. In Denmark, 25(OH)D
levels in healthy, non-pregnant volunteers have ranged
from 27 to 91 nmol/L [10,48-53] with deficiency varying
from 9% to 30% [10,48,54]. Measuring 25(OH)D levels
in 1,494 women in the DNBC, we found mean(SD) 25
(OH)D levels of 56.7(24.6) nmol/L; 42.3% of women
were classified as vitamin D deficient (<50 nmol/L) [11].
Some have argued that circulating 25(OH)D levels in ex-
cess of 100 nmol/L are necessary to optimize production
Table 1 Age-standardized covariates across quintiles of total vitamin D intake in 44,825 pregnant Danish women
(Continued)
Total vitamin C (mg/day) 191(135) 228(134) 235(136) 229(125) 264(161)
Total selenium (μg/day) 62.9(25.2) 90.3(22.3) 80.3(21.2) 81.8(15.8) 92.5(28.5)
Total zinc (mg/day) 18.8(7.2) 25.9(5.3) 22.4(5.6) 21.9(4.9) 24.4(9.3)
Values are means(SD) or percentages and are standardized to the age distribution of the study population.
1% or means (SD).
2Value is not age adjusted.
3Including fruit/vegetable juices.
EPA: Eicosapentaenoic acid.
DPA: Docosapentaenoic acid.
DHA: Docosahexaenoic acid.
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http://www.biomedcentral.com/1471-2393/13/199Table 2 Associations
1 between total vitamin D intake in mid-pregnancy and child asthma in the Danish National Birth Cohort
Quintile of
intake
Cases/N Asthma
(18 months)
N= 33,425/
29,161
2/28,421
3
P for
trend
4
Cases/N Current asthma
(7 years - ISAAC)
N=28,687/
25,025
2/24,382
3
P for
trend
4
Cases/N Ever admitted
asthma
N=28,767/
25,095
2/24,452
3
P for
trend
4
Cases/N Ever prescribed
asthma
N =28,758/
25,094
2/25,452
3
P for
trend
4
RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI)
Continuous Crude 5,635/33,425 (17%) 1.00 (0.99, 1.00) 0.90 1,122/28,687 (4%) 1.00 (0.99, 1.01) 0.73 1,654/28,767 (6%) 1.00 (0.99, 1.01) 0.88 8,906/28,758 (31%) 1.00 (1.00, 1.01) 0.04
Adjusted
2 1.00 (1.00, 1.01) 0.59 1.00 (0.99, 1.01) 0.88 1.00 (0.99, 1.01) 0.45 1.01 (1.00, 1.01) 0.15
Adjusted
3 1.00 (0.99, 1.01) 0.91 0.99 (0.97, 1.00) 0.09 0.99 (0.97, 1.00) 0.08 1.00 (0.99, 1.00) 0.30
1 Crude 1,123/6,627 (17%) 1.00 (ref.) 0.54 219/5,728 (4%) 1.00 (ref.) 0.67 344/5,743 (6%) 1.00 (ref.) 0.92 1,724/5,741 (30%) 1.00 (ref.) 0.05
Adjusted
2 0.85 0.70 0.41 0.21
Adjusted
3 0.40 0.06 0.06 0.36
2 Crude 1,137/6,836 (17%) 0.98 (0.91, 1.06) 218/5,936 (4%) 0.96 (0.80, 1.15) 318/5,953 (5%) 0.89 (0.77, 1.03) 1,811/5,953 (30%) 1.01 (0.96, 1.07)
Adjusted
2 1.01 (0.93, 1.09) 0.98 (0.81, 1.19) 0.92 (0.79, 1.08) 1.04 (0.98, 1.10)
Adjusted
3 1.00 (0.91, 1.10) 0.84 (0.67, 1.05) 0.88 (0.73, 1.06) 0.99 (0.93, 1.06)
3 Crude 1,170/6,725 (17%) 1.03 (0.95, 1.11) 231/5,710 (4%) 1.06 (0.88, 1.27) 341/5,725 (6%) 0.99 (0.86, 1.15) 1,798/5,721 (31%) 1.05 (0.99, 1.11)
Adjusted
2 1.04 (0.96, 1.12) 1.02 (0.84, 1.24) 0.96 (0.82, 1.12) 1.04 (0.98, 1.10)
Adjusted
3 1.00 (0.91, 1.11) 0.87 (0.69, 1.10) 0.90 (0.74, 1.09) 0.96 (0.90, 1.03)
4 Crude 1,146/6,714 (17%) 1.01 (0.93, 1.09) 247/5,702 (4%) 1.13 (0.95, 1.35) 331/5,714 (6%) 0.97 (0.84, 1.12) 1,810/5,712 (32%) 1.06 (1.00, 1.11)
Adjusted
2 1.01 (0.93, 1.09) 1.08 (0.90, 1.31) 0.92 (0.79, 1.08) 1.04 (0.98, 1.10)
Adjusted
3 0.96 (0.86, 1.07) 0.91 (0.71, 1.17) 0.80 (0.65, 0.99) 0.95 (0.88, 1.03)
5 Crude 1,059/6,523 (16%) 0.96 (0.89, 1.03) 207/5,611 (4%) 0.96 (0.80, 1.16) 320/5,632 (6%) 0.95 (0.82, 1.10) 1,763/5,631 (31%) 1.04 (0.99, 1.10)
Adjusted
2 0.99 (0.91, 1.07) 0.91 (0.75, 1.11) 0.92 (0.79, 1.08) 1.04 (0.98, 1.11)
Adjusted
3 0.96 (0.86, 1.07) 0.74 (0.56, 0.96) 0.80 (0.64, 1.00) 0.97 (0.89, 1.05)
1Analyzed using log-binomial models.
2Adjusted for maternal age, socio-economic status, parity, prepregnancy BMI, smoking during pregnancy, partner’s smoking during pregnancy, solarium use during pregnancy, breastfeeding duration, child sex,
maternal history of asthma, maternal history of allergies, paternal history of asthma, paternal history of allergies, season of last menstrual period, and energy (in quintiles).
3Adjusted as in
2 plus fruit and vegetable intake, alcohol consumption, and intake of total EPA + DPA + DHA, vitamins A, C, and E, folate, calcium, selenium, and zinc (all in quintiles).
4Median values for each quintile entered as a continuous variable into the model. For continuous exposure the P-value reflects the P-value of the effect estimate.
ISAAC: International Study of Asthma and Allergies in Childhood.
EPA: Eicosapentaenoic acid.
DPA: Docosapentaenoic acid.
DHA: Docosahexaenoic acid
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9Table 3 Associations
1 between vitamin D intake from supplements in mid-pregnancy and child asthma in the Danish National Birth Cohort
Quintile of
intake
Cases/N Asthma
(18 months)
N=33,425/
29,161
2/28,421
3
P for
trend
4
Cases/N Current asthma
(7 years - ISAAC)
N=28,686/
25,024
2/24,382
3
P for
trend
4
Cases/N Ever admitted
asthma
N= 28,766/
25,094
2/24,452
3
P for
trend
4
Cases/N Ever prescribed
asthma
N= 28,757/
25,093
2/24,452
3
P for
trend
4
RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI)
Continuous Crude 5,635/33,425 (17%) 1.01 (1.00, 1.01) 0.04 1,122/28,686 (4%) 1.01 (0.99, 1.02) 0.40 1,654/28,766 (6%) 1.00 (0.99, 1.01) 0.52 8,905/28,757 (31%) 1.01 (1.01, 1.01) <0.0001
Adjusted
2 1.00 (1.00, 1.01) 0.14 1.00 (0.99, 1.01) 0.99 1.00 (0.99, 1.01) 0.52 1.01 (1.00, 1.01) 0.01
Adjusted
3 1.00 (0.99, 1.01) 0.85 0.98 (0.97, 1.00) 0.10 0.99 (0.97, 1.00) 0.07 1.00 (0.99, 1.00) 0.65
1 Crude 835/5,071 (16%) 1.00 (ref.) 0.06 158/4,362 (4%) 1.00 (ref.) 0.18 251/4,375 (6%) 1.00 (ref.) 0.51 1,216/4,374 (28%) 1.00 (ref.) <0.0001
Adjusted
2 0.38 0.84 0.36 0.005
Adjusted
3 0.55 0.14 0.02 0.79
2 Crude 1,675/10,142 (17%) 1.00 (0.93, 1.08) 348/8,849 (4%) 1.09 (0.90, 1.31) 498/8,873 (6%) 0.98 (0.84, 1.13) 2,736/8,872 (31%) 1.11 (1.05, 1.17)
Adjusted
2 1.01 (0.94, 1.10) 1.07 (0.88, 1.30) 0.98 (0.84, 1.14) 1.12 (1.05, 1.19)
Adjusted
3 1.03 (0.91, 1.17) 1.05 (0.78, 1.41) 1.00 (0.78, 1.27) 1.11 (1.01, 1.22)
3 Crude 266/1,761 (15%) 0.92 (0.81, 1.04) 49/1,589 (3%) 0.85 (0.62, 1.17) 80/1,590 (5%) 0.88 (0.69, 1.12) 440/1,589 (28%) 1.00 (0.91, 1.09)
Adjusted
2 0.95 (0.83, 1.08) 0.78 (0.55, 1.10) 0.84 (0.64, 1.09) 1.02 (0.92, 1.12)
Adjusted
3 0.91 (0.78, 1.05) 0.62 (0.42, 0.90) 0.71 (0.53, 0.95) 0.96 (0.86, 1.07)
4 Crude 2,443/14,064 (17%) 1.05 (0.98, 1.13) 481/11,828 (4%) 1.12 (0.94, 1.34) 705/11,866 (6%) 1.04 (0.90, 1.19) 3,842/11,860 (32%) 1.16 (1.10, 1.23)
Adjusted
2 1.02 (0.95, 1.11) 1.06 (0.88, 1.27) 0.97 (0.83, 1.12) 1.12 (1.05, 1.18)
Adjusted
3 0.99 (0.87, 1.11) 0.97 (0.73, 1.29) 0.84 (0.67, 1.07) 1.05 (0.96, 1.15)
5 Crude 417/2,387 (17%) 1.06 (0.95, 1.18) 86/2,058 (4%) 1.15 (0.89, 1.49) 120/2,062 (6%) 1.01 (0.82, 1.25) 671/2,062 (33%) 1.17 (1.08, 1.27)
Adjusted
2 1.05 (0.94, 1.17) 1.01 (0.77, 1.34) 0.88 (0.70, 1.11) 1.11 (1.02, 1.21)
Adjusted
3 0.99 (0.86, 1.14) 0.81 (0.57, 1.15) 0.77 (0.58, 1.03) 1.03 (0.93, 1.15)
1Analyzed using log-binomial models.
2Adjusted for maternal age, socio-economic status, parity, prepregnancy BMI, smoking during pregnancy, partner’s smoking during pregnancy, solarium use during pregnancy, breastfeeding duration, child sex,
maternal history of asthma, maternal history of allergies, paternal history of asthma, and paternal history of allergies, season of last menstrual period, and energy (in quintiles).
3Adjusted as in
2 plus fruit and vegetable intake, alcohol consumption, and intake of total EPA + DPA + DHA, vitamins A, C, and E, folate, calcium, selenium, and zinc (all in quintiles).
4Median values for each quintile entered as a continuous variable into the model. For continuous exposure the P-value reflects the P-value of the effect estimate.
ISAAC: International Study of Asthma and Allergies in Childhood.
EPA: Eicosapentaenoic acid.
DPA: Docosapentaenoic acid.
DHA: Docosahexaenoic acid.
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9Table 4 Associations
1 between vitamin D intake in mid-pregnancy and self-reported child allergic rhinitis in the Danish National Birth Cohort
Quintile of
intake
Cases/N Allergic rhinitis by total
vitamin D N=28,545/
24,902
2/24,261
3
P for
trend
4
Cases/N Allergic rhinitis by vitamin D
from supplements N=28,544/
24,901
2/24,261
3
P for
trend
4
Cases/N Allergic rhinitis by vitamin D
from diet N=28,545/
24,902
2/24,261
3
P for
trend
4
RR (95% CI) RR (95% CI) R (95% CI)
Continuous Crude 1,420/28,545 (5%) 1.00 (1.00, 1.02) 0.33 1,420/28,544 (5%) 1.00 (0.99, 1.01) 0.51 1,420/28,545 (5%) 1.01 (0.99, 1.04) 0.31
Adjusted
2 1.00 (0.99, 1.01) 0.53 0.99 (0.98, 1.01) 0.38 1.01 (0.98, 1.03) 0.62
Adjusted
3 1.00 (0.99, 1.01) 0.97 1.00 (0.98, 1.01) 0.81 1.01 (0.97, 1.04) 0.65
1
Crude 263/5,700 (5%) 1.00 (ref.) 0.10 190/4,344 (4%) 1.00 (ref.) 0.28 296/5,646 (5%) 1.00 (ref.) 0.63
Adjusted
2 0.84 0.56 0.87
Adjusted
3 0.62 0.94 0.67
2
Crude 292/5,903 (5%) 1.07 (0.91, 1.26) 457/8,801 (5%) 1.19 (1.01, 1.40) 263/5,673 (5%) 0.88 (0.75, 1.04)
Adjusted
2 1.05 (0.89, 1.25) 1.12 (0.94, 1.33) 0.91 (0.76, 1.07)
Adjusted
3 1.10 (0.90, 1.34) 1.23 (0.95, 1.60) 0.91 (0.76, 1.08)
3
Crude 284/5,683 (5%) 1.08 (0.92, 1.28) 65/1,580 (4%) 0.94 (0.71, 1.24) 265/5,742 (5%) 0.88 (0.75, 1.03)
Adjusted
2 1.01 (0.85, 1.19) 0.96 (0.72, 1.27) 0.90 (0.76, 1.07)
Adjusted
3 1.14 (0.92, 1.41) 1.07 (0.78, 1.47) 0.88 (0.73, 1.08)
4
Crude 284/5,674 (5%) 1.08 (0.92, 1.28) 614/11,773 (5%) 1.19 (1.02, 1.40) 311/5,810 (5%) 1.02 (0.87, 1.19)
Adjusted
2 1.02 (0.86, 1.21) 1.06 (0.90, 1.26) 1.05 (0.89, 1.23)
Adjusted
3 1.11 (0.89, 1.40) 1.23 (0.95, 1.58) 1.04 (0.85, 1.28)
5
Crude 297/5,585 (5%) 1.15 (0.98, 1.35) 94/2,046 (5%) 1.05 (0.83, 1.34) 286/5,674 (5%) 0.96 (0.82, 1.13)
Adjusted
2 1.00 (0.84, 1.19) 0.90 (0.70, 1.16) 0.92 (0.78, 1.09)
Adjusted
3 1.08 (0.85, 1.37) 1.01 (0.74, 1.39) 0.89 (0.71, 1.13)
1Analyzed using log-binomial models.
2Adjusted for maternal age, socio-economic status, parity, prepregnancy BMI, smoking during pregnancy, partner’s smoking during pregnancy, solarium use during pregnancy, breastfeeding duration, child sex, mater-
nal history of asthma, maternal history of allergies, paternal history of asthma, and paternal history of allergies, season of last menstrual period, and energy (in quintiles).
3Adjusted as in
2 plus fruit and vegetable intake, alcohol consumption, and intake of total EPA + DPA + DHA, vitamins A, C, and E, folate, calcium, selenium, and zinc (all in quintiles).
4Median values for each quintile entered as a continuous variable into the model. For continuous exposure the P-value reflects the P-value of the effect estimate.
ISAAC: International Study of Asthma and Allergies in Childhood.
EPA: Eicosapentaenoic acid.
DPA: Docosapentaenoic acid.
DHA: Docosahexaenoic acid.
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9of 1,25(OH)2D [55] and that dietary intake of as much as
4,000 IU/day may be needed to reach those levels for cer-
tain deficient populations [47,56]. The Nordic Council of
Ministers currently recommends a daily intake of 10 μg/
day (400 IU/day) of vitamin D for all pregnant women
[39]. Our results did not indicate protection against child
asthma at this dosage. Rather, benefits for child asthma
appear to be derived at higher intake levels found in the
two upper quintiles. It is possible that more protective ef-
fects could have been found at even higher intake levels,
but the range of intake in our data did not allow us to
examine this. Furthermore, we found that the results were
limited to women with a prepregnancy BMI between 18.6
and 24.9 kg/m
2. Increased adiposity may decrease mater-
nal bioavailability of vitamin D [57] and consequently re-
duce fetal exposure to vitamin D. This finding needs to be
confirmed in future studies.
There have been few studies examining the association
between child asthma and vitamin D from dietary sources
and supplement use [19-21,27,28]. These studies have all
found inverse associations specific to diet, but were incon-
sistent across child asthma and allergic disease outcomes.
Majority of studies found that higher intake of dietary vita-
min D protected against wheeze up to 5 years [19-21]; our
results suggested only weak, non-significant associations
of dietary vitamin D with wheeze and recurrent wheeze
that disappeared after adjusting for dietary confounders.
One study also showed an inverse association for vitamin
D from supplements and recurrent wheeze at age 3 [19].
Maternal dietary vitamin D also seems to reduce the
child’s risk of eczema [21], bronchodilator response [20],
allergic rhinitis [28] and asthma [28]; we similarly found
an inverse association for asthma by self-report and hos-
pital admission at age 7. We did not find any evidence of
an association between maternal vitamin D intake and off-
spring allergic rhinitis or other asthma outcomes.
Despite a growing number of mechanistic studies, lit-
tle is still understood about vitamin D and allergic dis-
ease development. A primary mechanism in explaining
the potential relationship between vitamin D exposure
and allergic disease has involved Treg cells, a newly
uncovered set of immune cells with suppressive and
regulatory functions [58]. Animal and in vitro studies
have suggested that Treg cells may play a role in the
suppression of the Th2 response often found exagger-
ated in patients with allergic disease [59,60], and that
this suppression mechanism may be flawed in allergic
patients [61,62]. Vitamin D may influence Treg cells
through increased cell production [14,63] and by stimu-
lating IL-10 production, an anti-inflammatory and im-
munosuppressive cytokine that is also important for
Treg activation [64]. Mechanisms have also included
modification of antigen-presenting cell function [65],
inhibition of IgE production [66], and protection against
airway remodeling [67] and inflammation [68]. Other
studies seem to suggest that vitamin D may enhance the
Th2 response [69,70] or that dual responses may exist
[71]. Pichler et al. [72] demonstrated that vitamin D both
reduced IL-12–generated interferon -γ production and
suppressed IL-4 and IL-4 induced expression of IL-13 in
naive Th cells and cytotoxic T cells. These seemingly
contradictory findings may point to the importance of
timing of exposure in prenatal vs. mature immune cells.
While our data did not enable us to conclude anything
about timing of exposure, examining exposure at different
time points during pregnancy may be important in clarify-
ing these differences.
This study adds to the evidence on vitamin D intake in
pregnancy and child allergic disease and further research
on early respiratory outcomes. Strengths of our study
include following a large, prospective cohort with com-
prehensive data on vitamin D from both diet and sup-
plements. We were also able to include an extensive
outcome assessment using data from questionnaires and
two population-based disease registries, a unique strength
in our setting. We included outcomes in both early and
later childhood, taking into consideration potentially dif-
ferent etiologies of similar symptom manifestations across
childhood. Early wheeze and asthma diagnosis made in
the first years of life may primarily include transient or
viral wheeze, which would explain the higher prevalence
of asthma at 18 months [45]. On the other hand, asthma
development peaks at around 5–6 years; hence, later diag-
nosis and clinical diagnoses in registries may capture more
clinical asthma. For our later outcomes we used questions
validated by ISAAC and a patient registry that has demon-
strated good validity in previous studies [73]. We found a
slightly stronger association for inpatient diagnoses, sug-
gesting potential importance of disease severity. The sig-
nificant findings in this analysis appeared to be influenced
by adjustment for dietary variables. Upon further examin-
ation we found that total zinc intake was responsible for
the greatest change in effect estimates for ever admitted
asthma. No single nutrient appeared to drive the changes
for current asthma at age 7. Maternal total zinc intake was
inversely related to total vitamin D consumption and to
child asthma, independent of other dietary variables.
This suggests that zinc may be a positive confounder
and explain the downward shift in effect estimates after
adjustment. We believe that the adjustment for both
sociodemographic and dietary covariates minimized re-
sidual confounding.
Our study had some potential limitations. Maternal
dietary exposure was self-reported and therefore prone
to misclassification; yet, we expect any misclassification
to have been non-differential and underestimate the
strength of observed associations. This together with the
low levels and low variability in intake, especially for
Maslova et al. BMC Pregnancy and Childbirth 2013, 13:199 Page 11 of 14
http://www.biomedcentral.com/1471-2393/13/199diet, may have limited our ability to capture significant
associations. We used maternal dietary exposure during
one time point in pregnancy. Other time intervals may be
important and need to be examined more closely in order
to establish the period of etiological relevance. Although
we did not have access to serum levels of vitamin D, we
considered numerous determinants of vitamin D status in
our models, including leisure time activity, outdoor occu-
pation, tanning beds and vacationing in sun-exposed
countries. While serum levels give a measure of vitamin D
exposure from diet and sunlight, supplementation is
more pertinent in making recommendations to preg-
nant women. We cannot exclude that correlations with
other nutrients may be responsible for the observed asso-
ciations; however, Spearman correlations coefficients for
nutrients included as covariates, such as total vitamin E
and C, zinc and selenium intake, were all below 0.25 (data
not shown).
In order to capture potentially different asthmatic
phenotypes we included asthma outcomes from different
sources, and we were not able to demonstrate an effect of
the exposure on two of the asthma outcomes. Asthma at
18 months may have largely consisted of transient wheeze,
while ever prescribed asthma may have included cases
ranging from suspect asthma to more severe disease in
need of medication [74]. Consequently, a lower specificity
for the latter and a subsequent attenuating of the effect
measures may account for the failure to detect an associ-
ation. The exclusion of potential transient wheeze in the
first three years of life, considerably reducing the number
of cases, strengthened the association for ever prescribed
asthma, but it did not reach statistical significance. Finally,
attrition is a concern in longitudinal studies in regards to
potential for selection bias. However, upon examining
characteristics between participants and non-participants
we found few minor differences, suggesting limited bias.
Conclusions
In this large, prospective study of maternal dietary and
supplement vitamin D intake in mid-pregnancy and
child asthma, we found weak inverse associations for
total vitamin D with ever admitted asthma and current
asthma at 7 years, but not with outcomes at 18 months
or ever allergic rhinitis at 7 years. We cannot exclude
that these associations may have been due to residual
confounding. Although the vitamin D intake in our
population was in accordance with the current recom-
mendations for intake during pregnancy, the inverse asso-
ciation was not seen at recommended dosage level. Two
clinical trials of maternal vitamin D supplementation and
child asthma (NCT00920621 and NCT00856947) are
currently underway. While randomized clinical trials
are considered to be the gold standard, observational
studies may be more appropriate for answering questions
on nutrient dosage. As noted in a recent commentary, tri-
als are limited by the nutrient range that can be examined
and the baseline nutrient level that can be included due to
both feasibility and ethical issues, and follow-up of dis-
eases developing years later may not be possible in most
settings [75].
Future studies should delineate the importance of ex-
posure timing as well as relevant dosage level in pregnancy
as this will have clinical relevance in making recommen-
dations to pregnant women.
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